Baxter
BAX
#2183
Rank
โ‚ฌ7.44 B
Marketcap
14,42ย โ‚ฌ
Share price
-0.18%
Change (1 day)
-43.97%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Revenue for Baxter (BAX)

Revenue in 2025 (TTM): โ‚ฌ9.75 Billion

According to Baxter's latest financial reports the company's current revenue (TTM ) is โ‚ฌ9.74 Billion. a decrease over the revenue in the year 2024 that were of โ‚ฌ10.22 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Baxter from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ9.57 B-6.35%
2024 โ‚ฌ10.22 B-17.55%
2023 โ‚ฌ12.39 B-10.13%
2022 โ‚ฌ13.79 B22.2%
2021 โ‚ฌ11.28 B18.95%
2020 โ‚ฌ9.49 B-6.43%
2019 โ‚ฌ10.14 B4.33%
2018 โ‚ฌ9.72 B10.44%
2017 โ‚ฌ8.80 B-8.9%
2016 โ‚ฌ9.66 B5.98%
2015 โ‚ฌ9.11 B-26.97%
2014 โ‚ฌ12.48 B13.46%
2013 โ‚ฌ11.00 B2.57%
2012 โ‚ฌ10.72 B0.28%
2011 โ‚ฌ10.69 B10.8%
2010 โ‚ฌ9.65 B10.12%
2009 โ‚ฌ8.76 B-0.73%
2008 โ‚ฌ8.83 B14.5%
2007 โ‚ฌ7.71 B-1.92%
2006 โ‚ฌ7.86 B-5.4%
2005 โ‚ฌ8.31 B18.61%
2004 โ‚ฌ7.00 B-1%
2003 โ‚ฌ7.08 B-7.88%
2002 โ‚ฌ7.68 B-11.42%
2001 โ‚ฌ8.67 B18.53%
2000 โ‚ฌ7.32 B15.46%
1999 โ‚ฌ6.34 B22.34%
1998 โ‚ฌ5.18 B0.2%
1997 โ‚ฌ5.17 B12.87%
1996 โ‚ฌ4.58 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Medtronic
MDT
โ‚ฌ30.73 B 215.57%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
โ‚ฌ38.59 B 296.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚ฌ18.99 B 94.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
โ‚ฌ17.39 B 78.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
โ‚ฌ21.75 B 123.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
โ‚ฌ211.96 B 2,076.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
โ‚ฌ1.93 B-80.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚ฌ1.20 B-87.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
โ‚ฌ5.81 B-40.35%๐Ÿ‡บ๐Ÿ‡ธ USA
CryoLife
CRY
โ‚ฌ0.25 B-97.34%๐Ÿ‡บ๐Ÿ‡ธ USA